Groups Sue FDA Over Enforcement Guidance for Unauthorized Vapes, Nicotine Pouches

On July 14, 2026, a coalition of public health organizations, pediatricians, and parents filed a federal lawsuit challenging an FDA policy issued in May 2026. The policy lays out when the agency says it generally will not prioritize enforcement against certain electronic nicotine delivery systems (ENDS—often called vapes) and nicotine pouch products that have not received FDA’s required premarket authorization.

The dispute matters because “enforcement priorities” can shape what remains on shelves and online while FDA reviews applications. FDA says its guidance is not authorization—it’s about how it intends to allocate enforcement resources in limited circumstances.

What FDA issued in May 2026

In guidance dated May 8, 2026, FDA described enforcement priorities for certain new tobacco products marketed without premarket authorization. FDA says the document does not create legally enforceable obligations and is nonbinding.

FDA also says it will create and maintain a publicly available list identifying manufacturers and products that fall within the categories where FDA says it generally does not intend to prioritize enforcement.

Under the policy, FDA says it generally does not intend to prioritize enforcement of the premarket authorization requirement where a covered product has a pending application that has been accepted and filed, or where a supplemental PMTA (sPMTA) has been accepted and is pending for more than 180 days. For certain non-tobacco-flavored ENDS products, FDA also adds an additional condition tied to whether FDA has determined the application includes data needed for evaluation under the public health standard.

FDA adds guardrails: the agency says it does not intend to apply the non-prioritization approach if the product has “presumptively underage-appealing” elements (such as depicting a cartoon-like fictional character, disguising it as a vaping product, or resembling a children’s toy, phone, or gaming platform) or if FDA determines the product presents a significant public health or safety concern—examples include high nicotine content, serious adverse experiences, lack of child-resistant packaging, or potential fire hazard.

Importantly for readers: FDA says a product’s inclusion in these enforcement categories has no bearing on whether the tobacco product will receive premarket authorization.

The lawsuit: what challengers say the policy does

The case was filed in the U.S. District Court for the District of Maryland (case number 8:2026cv02767). The docket listing shows plaintiffs including the Campaign for Tobacco-Free Kids, the American Academy of Pediatrics, the American Cancer Society Cancer Action Network, the American Heart Association, the American Lung Association, Parents Against Vaping e-Cigarettes, Truth Initiative, and individual plaintiffs.

According to the plaintiffs’ allegations as described in coverage and their public-facing explanations, the challenge argues FDA’s guidance unlawfully allows unauthorized products to be marketed without the scientific review and prior authorization required by federal law. The lawsuit also alleges the agency should have followed public notice-and-comment requirements and that FDA acted “arbitrary and capricious” by creating what plaintiffs describe as an “enforcement safe harbor.”

This filing is not a court decision on the merits—it starts the process where both sides can argue what the guidance means legally and what remedy, if any, a judge should order.

What to watch next

The next developments are procedural but potentially consequential. Watch the court docket for any requests for emergency relief that could change FDA’s enforcement posture for products covered by the guidance. On the agency side, keep an eye on whether FDA revises, clarifies, or further implements the May 2026 policy—especially around how it operationalizes the promised public list.

Sources

• FDA Center for Tobacco Products (CTP) newsroom: May 8, 2026 guidance overview
• U.S. District Court docket (District of Maryland) via Justia: Campaign For Tobacco-Free Kids et al v. FDA (8:2026cv02767)
• Truth Initiative press release: lawsuit summary and plaintiff list (July 14, 2026 coverage)
• Bloomberg Law (July 14, 2026): reporting on the FDA enforcement-policy lawsuit